Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients. [electronic resource]
- Transactions of the Royal Society of Tropical Medicine and Hygiene Mar 2014
- 176-8 p. digital
Publication Type: Journal Article
1878-3503
10.1093/trstmh/tru011 doi
Adult Aged Aged, 80 and over Amphotericin B--therapeutic use Antiprotozoal Agents--therapeutic use Dose-Response Relationship, Drug Female Humans Leishmaniasis, Mucocutaneous--drug therapy Male Middle Aged Retrospective Studies